Vitamin E reduces liver stiffness in nonalcoholic fatty liver disease

Figure 2 Effects of vitamin E treatment on liver enzyme levels. ^aIndicate a difference when the results are compared with baseline values (P < 0.05). A: Evolution of AST during the study period. Serum AST levels in all patients decreased from baseline to 6 and 12 mo (P < 0.001 and P < 0.001, respectively). Serum AST levels in the CC/CG group decreased from baseline to 6 and 12 mo (P = 0.004 and P < 0.001, respectively). Serum AST levels in the GG group also decreased from baseline to 6 and 12 mo (P = 0.045 and P = 0.011, respectively); B: Evolution of ALT during the study period. Serum ALT levels in all patients decreased from baseline to 6 and 12 mo (P < 0.001 and P < 0.001, respectively). Serum ALT levels in the CC/CG group decreased from baseline to 6 and 12 mo (P = 0.022 and P < 0.001, respectively). Serum ALT levels in the GG group also decreased from baseline to 6 and 12 mo (P = 0.004 and P < 0.001, respectively); C: Evolution of γ-GTP during the study period. Serum γ-GTP levels in all patients decreased from baseline to 6 and 12 mo (P = 0.019 and P < 0.001, respectively). Serum γ-GTP levels in the CC/CG group decreased from baseline to 6 and 12 mo (P = 0.047 and P = 0.003, respectively). Those in the GG group decreased from baseline to 12 mo (P = 0.005). AST: Aspartate aminotransferase; ALT: Alanine aminotranferease; γ-GTP: γ-glutamyl transpeptidase.